Answer
Starting Fabhalta (iptacopan) is contraindicated in patients with unresolved infection caused by encapsulated bacteria, including Neisseria meningitidis, Streptococcus pneumoniae or Haemophilus influenzae type B.
Sources for this answer
- FABHALTA 200 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked